Milanova Tsveta

CIK 00019571801 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001957180

Recent Transactions

30 trades

Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-01-05−8,475→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-01-05$27.02/sh−2,872→ 34,793 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-01-05+8,475→ 37,665 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30+6,000→ 32,122 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-12-30−6,000→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30$27.09/sh−2,932→ 29,190 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24+6,000→ 28,892 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-06-24−6,000→ 6,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24$33.54/sh−2,770→ 26,122 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,681→ 22,892 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-03-01+43,500→ 43,500 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+5,667→ 24,573 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01+12,000→ 12,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−5,667→ 11,333 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-01-06$32.18/sh−2,804→ 18,906 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-01-03+8,476→ 21,710 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-01-03−8,476→ 8,475 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-03-01+17,000→ 17,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-03-01+60,000→ 60,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-24$21.64/sh−1,618→ 13,234 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2024-01-20−5,448→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-20+5,448→ 14,852 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-05$22.32/sh−2,902→ 9,404 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-01-03+8,475→ 12,306 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-01-03−8,475→ 16,951 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-30$28.36/sh−1,618→ 3,831 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2023-06-28−5,449→ 5,448 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-28+5,449→ 5,449 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-01-03+25,426→ 25,426 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2023-01-03+135,682→ 135,682 total

Companies

AGIOS PHARMACEUTICALS, INC.
Chief Commercial Officer
$AGIO

Recent Filings

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov